What to know when applying for disability with MG
Applying for disability with MG can feel overwhelming, but preparation makes a real difference.
Applying for disability with MG can feel overwhelming, but preparation makes a real difference.
Secukinumab was linked to rapid symptom and quality-of-life improvements in people with AChR-positive MG in a small retrospective study.
A study tracked MG patients for 12 months after COVID-19 to examine how lingering symptoms related to disease exacerbations.
New data show increasing incidence and prevalence of myasthenia gravis in U.S. adults, with high exacerbation rates.